Sex-Dependent Risk of Postoperative Delirium and Mediating Effects of Family Visits

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age65+
SponsorJulian Rössler

About this trial

Postoperative delirium is a common and serious complication after surgery, affecting 10-40% of older patients undergoing non-cardiac procedures. It is characterized by sudden changes in attention, awareness, and thinking that fluctuate throughout the day. Delirium is associated with longer hospital stays, higher mortality, worse long-term brain function, and substantially increased healthcare costs. While several risk factors are known, it remains unclear whether a patient's sex independently influences the risk of developing postoperative delirium, as existing studies have produced conflicting results and were often not designed to specifically examine sex differences.Family visitation is a promising non-drug approach to preventing delirium. Studies in intensive care patients have shown that those who receive family visits have a significantly lower risk of developing delirium. However, it is unknown whether men and women receive different amounts of family visits after surgery, and whether any such difference could help explain sex-based disparities in delirium risk. Given that traditional gender roles in caregiving persist, women - who often serve as primary caregivers in their families - may receive fewer visits when they themselves become patients.This prospective observational study led by the University of Zurich will enroll 471 patients aged 65 years or older undergoing non-cardiac surgery lasting at least 2 hours under general or spinal anesthesia. The primary aim is to determine whether female patients have a higher risk of developing postoperative delirium within three days after surgery compared to male patients. Delirium will be assessed twice daily using the 4 A's Test (4AT), a validated and standardized screening tool. The secondary aim is to evaluate whether female patients receive fewer family visits than male patients and whether any difference in visitation mediates the sex-dependent delirium risk. Family visits will be recorded using an anonymous sign-in sheet placed in the patient's room. The study does not involve any experimental interventions; all patients receive standard clinical care. Participation is voluntary, and withdrawal is possible at any time without affecting medical treatment.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Informed consent as documented by signature;

≥65 years of age;

Scheduled non-cardiac surgery with expected surgery duration ≥ 2 hours;

Under either general or spinal anesthesia.

Disqualifiers

Known drug or alcohol abuse;

Requirement for postoperative ventilation;

Current participation in another study with an investigational drug;

Inability to complete the study assessments.

Trial population

Patients aged 65 and older who are having noncardiac surgery

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

471 Participants
are grouped into 2 trial groups
Group A: Female
Group B: Male

Trial outcomes

Primary outcomes

1

Postoperative Delirium

The primary outcome is presence of delirium as assessed by the 4AT test. A 4AT score of 4 or above will be used for dichotomous assessment of the primary outcome presence of delirium. Participants will be assessed daily in the morning and the evening.

Time frame
Starting on postoperative day (POD) 1 and continuing until POD 3, or discharge - whichever comes first.

Secondary outcomes

1

Family Visits

The secondary outcome is hours spend being visited. Visits shall be self-reported by the visiting party. All visits regardless of relation to the participant (e.g., family, friends, or colleagues) shall be reported. Visits should be recorded in hourly intervals, regardless of the number of visitors present (e.g., two visitors for one hour, or one visitor for one hour, should counted as the same).

Time frame
Starting on postoperative day (POD) 1 and continuing until POD 3, or discharge - whichever comes first

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Julian Rössler

Lead sponsor

University of Zurich

Sponsor institution